# Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke

> **NCT00452582** · PHASE1 · TERMINATED · sponsor: **Henry Ford Health System** · enrollment: 20 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Sildenafil (Viagra)
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT00452582
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Failure to recruit in expected time period.
- **Last updated:** 2011-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452582, "Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00452582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*